NDC 71335-3187-01: Foster and Thrive Chest Congestion Relief DM DM Dextromethorphan Hydrobromide / Guaifenesin 20 mg; 400 mg Tablet, Bottle of 50
This is a package of 50 tablets of Foster and Thrive Chest Congestion Relief DM DM Dextromethorphan Hydrobromide / Guaifenesin 20 mg; 400 mg Tablet from Bryant Ranch Prepack, first listed with the FDA Jan 2023 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 71335-3187-1 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 71335 labeler · 3187 product · 1 package
- Package marketed since
- Oct 15, 2026
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 7133531871 0
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1147685
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
This is an oral tablet sold over the counter under FDA's OTC monograph system, which sets standard rules for this category rather than reviewing each product individually. It contains two active ingredients: dextromethorphan hydrobromide and guaifenesin. Dextromethorphan is typically used as a cough suppressant, meaning it acts on the cough reflex in the brain. Guaifenesin is commonly used as an expectorant, a substance intended to loosen mucus in the airways so it is easier to clear.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 71335-3187-01 You're viewing this Main listing | 1 BOTTLE in 1 CARTON / 50 TABLET in 1 BOTTLE | 2026-10-15 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Quality Choice Mucus Relief DM DM 20 mg/1; 400 mg 63868-0753-50 | Chain | 50 tablets | $0.074 | — | FDA listed | — |
| Sunmark Chest Congestion Relief DM DM 20 mg/1; 400 mg 49348-0728-09 | Strategic | 50 tablets | $0.080 | — | FDA listed | — |
| Quality Choice Mucus Relief DM DM 20 mg/1; 400 mg 83324-0195-50 | Chain | 50 tablets | $0.083 | — | Availability likely | — |
| Rugby Chest Congestion Relief DM 20 mg/1; 400 mg 00536-1312-08 | Rugby | 60 tablets | $0.083 | — | Availability likely | — |
| Good Neighbor Pharmacy Mucus Relief DM 20 mg/1; 400 mg 24385-0026-71 | AmerisourceBergen | 50 tablets | $0.083 | — | Availability likely | — |
| Leader Chest Congestion Relief DM 20 mg/1; 400 mg 70000-0056-01 | Cardinal | 60 tablets | $0.083 | — | Availability likely | — |
| Foster and Thrive Chest Congestion Relief DM DM 20 mg/1; 400 mg 70677-1055-01 | Strategic | 50 tablets | $0.083 | — | Availability likely | — |
| Equaline Chest Congestion Relief DM DM 20 mg/1; 400 mg 41163-0114-50 | United | 50 tablets | — | — | FDA listed | — |
| CVS Chest Congestion Relief DM 20 mg/1; 400 mg 69842-0996-30 | CVS | 30 tablets | — | — | FDA listed | — |
| Refenesen Mucus Relief DM 20 mg/1; 400 mg 10956-0846-30 | Reese | 30 tablets | — | — | FDA listed | — |
| Kroger Chest Congestion Relief DM 20 mg/1; 400 mg 30142-0472-30 | THE | 30 tablets | — | — | FDA listed | — |
| TopCare Chest Congestion and Cough Relief DM 20 mg/1; 400 mg 36800-0988-50 | TOPCO | 30 tablets | — | — | FDA listed | — |
| Always Save Chest Congestion Relief DM 20 mg/1; 400 mg 63941-0985-50 | Valu | 50 tablets | — | — | FDA listed | — |
| Rugby Chest Congestion Relief DM 20 mg/1; 400 mg 71335-2216-01 | Bryant | 30 tablets | — | — | FDA listed | — |
| Care One Chest Congestion Relief DM 20 mg/1; 400 mg 72476-0871-50 | RETAIL | 50 tablets | — | — | FDA listed | — |
| Marcs Chest Congestion Relief DM 20 mg/1; 400 mg 68998-0114-50 | Marc | 50 tablets | — | — | FDA listed | — |
| Family Wellness Chest Congestion Relief DM DM 20 mg/1; 400 mg 55319-0890-30 | Family | 30 tablets | — | — | FDA listed | — |
| Dollar General Chest Congestion Relief DM 20 mg/1; 400 mg 55910-0272-30 | Dolgencorp, | 30 tablets | — | — | FDA listed | — |
| Foster and Thrive Chest Congestion Relief DM DM 20 mg/1; 400 mgthis 71335-3187-01 | Bryant | 50 tablets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 7CVR7L4A2D
A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
5 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Bryant Ranch Prepack labeler code 71335
- PredniSONE 5 mg Tablet NDC 71335-3181-0
- Dexamethasone 4 mg Tablet NDC 71335-3182-1
- Levothyroxine Sodium 137 ug Tablet NDC 71335-3183-1
- Fluoxetine 10 mg Capsule NDC 71335-3184-1
- Dexamethasone 6 mg Tablet NDC 71335-3185-1
- Valsartan 160 mg Tablet, Film Coated NDC 71335-3186-1
- Olmesartan Medoxomil 20 mg Tablet, Film Coated NDC 71335-3189-1
- tadalafil 2.5 mg Tablet, Film Coated NDC 71335-3190-1
- Metoprolol Tartrate 50 mg Tablet NDC 71335-3191-1
- Atenolol 25 mg Tablet NDC 71335-3192-1
- Meloxicam 15 mg Tablet NDC 71335-3194-1
- Cyclobenzaprine Hydrochloride 7.5 mg Tablet, Film Coated NDC 71335-3195-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses ■ Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a common cold ■ Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus ■ Helps make coughs more productive.
⏱️ Dosage and Administration ▾
Directions ■ Adults and children 12 years of age and over : take 1 tablet every 4 hours as needed. ■ Children 6 to 10 under 12 years of age: take 1/2 tablet every 4 hours as needed. ■ Children under 6 years of age: consult a doctor. Do not exceed 6 doses in a 24 hour period or as directed by a doctor
⚠️ Warnings ▾
Warnings Do not use ■ if you are now taking a prescription monoamine oxidase (inhiMor~MAIO) (Certain drugs for depression, psychiatric or emotional conditioners or Parkinson's disease)or for 2 weeks after stopping MAIO drug, If you do not know if your prescription drug contains an MAIO, ask your doctor or pharmacist before using this product.
📦 How Supplied / Storage and Handling ▾
HOW SUPPLIED Guaifenesin and Dextromethorphan Hydrobromide 400mg/20mg Tablets NDC 71335-3187-1: 30 Tablets in a BOTTLE NDC 71335-3187-2: 20 Tablets in a BOTTLE NDC 71335-3187-3: 18 Tablets in a BOTTLE NDC 71335-3187-4: 60 Tablets in a BOTTLE Store at 15°-30°C (59°-86°F) Repackaged/Relabeled by: Bryant Ranch Prepack Burbank, CA 91504
📦 Storage and Handling ▾
Other Information Store at 15°-30°C (59°-86°F)
🧪 Active Ingredient ▾
Active ingredient - (per tablet) Dextromethorphan Hydrobromide 20mg Guaifenesin 400mg
🧪 Inactive Ingredients ▾
Inactive Ingredients magnesium stearate, microcrystalline cellulose. May also contain (colloidal) silicon dioxide, (co) povidone, dicalcium phosphate, maltodextrin, sodium starch glycolate, stearic acid.
🎯 Purpose ▾
Purpose Cough Suppressant Expectorant
📄 Ask a Doctor Before Use If ▾
Ask doctor before use if you have ■ persistent or chronic cough, such as occurs with smoking, asthma, bronchitis or emphysma ■ cough is accompanied by excessive phlegm (mucus)
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask doctor if ■ symptoms are accompanied by fever, rash or persistent headache ■ cough persists for more than 1 week or tends to recur. A persistent cough may be a sign of a serious condition.
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Center immediately.
📄 Package Label / Principal Display Panel ▾
Guaifenesin and Dextromethorphan Hydrobromide 400mg/20mg Tablets Label
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |